News Column

PEREGRINE PHARMACEUTICALS INC FILES (8-K) Disclosing Other Events

February 6, 2014



Item 8.01 Other Events.

Peregrine Pharmaceuticals, Inc. reports that it raised $27.4 million in net proceeds during the quarter ended January 31, 2014 under an At Market Sales Issuance Agreement and ended the quarter with over $63 million in cash and cash equivalents. During the quarter ended January 31, 2014, the Company sold 16,045,717 shares of common stock at an average selling price of $1.75 per share before deducting commissions. The Company will report financial results for the third quarter of its fiscal year 2014 ended January 31, 2014 on March 7, 2014.


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools